Bioenergetic Cardiology & the Awesome Foursome
-
Stephen T. Sinatra (1946 – 2022) was a board-certified cardiologist specializing in integrative medicine. He studied coenzyme Q10 in the prevention and treatment of heart disease. His experience with CoQ10 led him to develop a new branch of cardiology: "metabolic cardiology."
Metabolic cardiology involves preventing and treating cardiovascular disease at the cellular level with nutraceuticals which improve ATP production in heart cells. He wrote, “Bioenergetics is at the Core of Metabolic Cardiology”.
The four nutraceuticals for heart health he referred to as “The Awesome Foursome”:
1. Magnesium:
2. CoQ10: there are two forms one is called ubiquinone and the other is called ubiquinol, ubiquinol is a little more powerful (and expensive), but both work.
3. L-Carnitine: a fatty acid shuttle into mitochondria.
4. D-Ribose: building blocks for your cells energy needs.Dr. Sinatra wrote that these specific nutrients are worth trying to see if they help you feel better and help your heart and other cells to work well. He made a presentation in 2015 describing the impact of these nutraceuticals on heart health. Here is his presentation which is entitled “Healing the Heart”.
On his website he wrote Metabolic-cardiology-Basics.
Dr. Sinatra also authored several books that are available at retailers.
-
-
@DavidPS L carnitine can cause heart attacks due to the pro fatty acid oxidation effect, raises cortisol also. Mildronate used to block l carnitine improves heart failure and CVD.
-
@Razvan said in Bioenergetic Cardiology & the Awesome Foursome:
L carnitine can cause heart attacks due to the pro fatty acid oxidation effect, raises cortisol also.
Thanks, I generally think that dose makes the poison. L-carnitine is part of many healthy diets and may be deficient in elderly with heart issues who do not eat enough meat.
6 Foods High in L-Carnitine That Are Really Good for You
Strangely, the delivery method also matters. Eating foods containing L-carnitine will have a different effect than injecting it.
Conclusion: Compared with placebo or control, L-carnitine is associated with a 27% reduction in all-cause mortality, a 65% reduction in VAs, and a 40% reduction in anginal symptoms in patients experiencing an acute myocardial infarction. Further study with large randomized controlled trials of this inexpensive and safe therapy in the modern era is warranted.